Postsynaptic diacylglycerol lipase α mediates retrograde endocannabinoid suppression of inhibition in mouse prefrontal cortex

Journal of Physiology

Volumn 589, Issue 20, 2011, Pages 4857-4884

  Yoshino, Hiroki ^a   Miyamae, Takeaki ^a   Hansen, Gwenn ^b   Zambrowicz, Brian ^b   Flynn, Michael ^c   Pedicord, Donna ^c   Blat, Yuval ^c   Westphal, Ryan S ^c   Zaczek, Robert ^c   Lewis, David A ^a   Gonzalez Burgos, Guillermo ^a  

^a UNIVERSITY OF PITTSBURGH SCHOOL OF MEDICINE   (United States)

^b LEXICON PHARMACEUTICALS INC   (United States)

^c BRISTOL MYERS SQUIBB   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

2 ARACHIDONOYLGLYCEROL; ANANDAMIDE; CARBACHOL; ENDOCANNABINOID; ISOENZYME; LIPOPROTEIN LIPASE; MESSENGER RNA; RETROVIRUS VECTOR; TETRAHYDROLIPSTATIN;

ACTION POTENTIAL; ANIMAL CELL; ANIMAL TISSUE; ARTICLE; BRAIN TISSUE; CONTROLLED STUDY; DEPOLARIZATION; DRUG ACTIVITY; DRUG MECHANISM; ELECTROPHYSIOLOGY; ENZYME ACTIVITY; ENZYME DEGRADATION; ENZYME INHIBITION; LIPID METABOLISM; MOUSE; MUTAGENESIS; NONHUMAN; POSTSYNAPTIC POTENTIAL; PREFRONTAL CORTEX; PRIORITY JOURNAL; PYRAMIDAL NERVE CELL; SYNAPTIC TRANSMISSION; VOLTAGE CLAMP;

ANIMALS; ARACHIDONIC ACIDS; CARBACHOL; CHOLINERGIC AGONISTS; ENDOCANNABINOIDS; ENZYME INHIBITORS; GLYCERIDES; INHIBITORY POSTSYNAPTIC POTENTIALS; ISOENZYMES; LIPOPROTEIN LIPASE; MALE; MICE; MICE, INBRED C57BL; MICE, KNOCKOUT; NEURAL INHIBITION; PATCH-CLAMP TECHNIQUES; POLYUNSATURATED ALKAMIDES; PREFRONTAL CORTEX; PYRAMIDAL CELLS;

EID: 80054101176     PISSN: 00223751     EISSN: 14697793     Source Type: Journal    
DOI: 10.1113/jphysiol.2011.212225     Document Type: Article

References (103)

1. Aguiar DC, Terzian AL, Guimaraes FS & Moreira FA (2009). Anxiolytic-like effects induced by blockade of transient receptor potential vanilloid type 1 (TRPV1) channels in the medial prefrontal cortex of rats. Psychopharmacology (Berl) 205, 217-225.
2. Alger BE & Kim J (2011). Supply and demand for endocannabinoids. Trends Neurosci 34, 304-315.
3. Ali AB (2011). CB1 modulation of temporally distinct synaptic facilitation among local circuit interneurons mediated by N-type calcium channels in CA1. J Neurophysiol 105, 1051-1062.
4. Bacci A, Huguenard JR & Prince DA (2004). Long-lasting self-inhibition of neocortical interneurons mediated by endocannabinoids. Nature 431, 312-316.
5. Baeg EH, Kim YB, Huh K, Mook-Jung I, Kim HT & Jung MW (2003). Dynamics of population code for working memory in the prefrontal cortex. Neuron 40, 177-188.
6. Bisogno T, Cascio MG, Saha B, Mahadevan A, Urbani P, Minassi A, Appendino G, Saturnino C, Martin B, Razdan R & Di Marzo V (2006). Development of the first potent and specific inhibitors of endocannabinoid biosynthesis. Biochim Biophys Acta 1761, 205-212.
7. Bisogno T, Howell F, Williams G, Minassi A, Cascio MG, Ligresti A, Matias I, Schiano-Moriello A, Paul P, Williams EJ, Gangadharan U, Hobbs C, Di Marzo V & Doherty P (2003). Cloning of the first sn1-DAG lipases points to the spatial and temporal regulation of endocannabinoid signaling in the brain. J Cell Biol 163, 463-468.
8. Bodor AL, Katona I, Nyiri G, Mackie K, Ledent C, Hajos N & Freund TF (2005). Endocannabinoid signaling in rat somatosensory cortex: laminar differences and involvement of specific interneuron types. J Neurosci 25, 6845-6856.
9. Buczynski MW & Parsons LH (2010). Quantification of brain endocannabinoid levels: methods, interpretations and pitfalls. Br J Pharmacol 160, 423-442.
10. 9-tetrahydrocannabinol exposure. Br J Pharmacol 161, 103-112.
11. Carter E & Wang XJ (2007). Cannabinoid-mediated disinhibition and working memory: dynamical interplay of multiple feedback mechanisms in a continuous attractor model of prefrontal cortex. Cereb Cortex 17 (Suppl. 1), i16-i26.
12. Cea-del Rio CA, Lawrence JJ, Tricoire L, Erdelyi F, Szabo G & McBain CJ (2010). M3 muscarinic acetylcholine receptor expression confers differential cholinergic modulation to neurochemically distinct hippocampal basket cell subtypes. J Neurosci 30, 6011-6024.
13. Chavez AE, Chiu CQ & Castillo PE (2010). TRPV1 activation by endogenous anandamide triggers postsynaptic long-term depression in dentate gyrus. Nat Neurosci 13, 1511-1518.
14. Chevaleyre V & Castillo PE (2003). Heterosynaptic LTD of hippocampal GABAergic synapses: a novel role of endocannabinoids in regulating excitability. Neuron 38, 461-472.
15. Chiu CQ, Puente N, Grandes P & Castillo PE (2010). Dopaminergic modulation of endocannabinoid-mediated plasticity at GABAergic synapses in the prefrontal cortex. J Neurosci 30, 7236-7248.
16. A receptor mediated synaptic function in cultured hippocampal neurons. Exp Neurol 229, 264-273.
17. Di Marzo V (2011). Endocannabinoid signaling in the brain: biosynthetic mechanisms in the limelight. Nat Neurosci 14, 9-15.
18. Dinh TP, Carpenter D, Leslie FM, Freund TF, Katona I, Sensi SL, Kathuria S & Piomelli D (2002). Brain monoglyceride lipase participating in endocannabinoid inactivation. Proc Natl Acad Sci U S A 99, 10819-10824.
19. Drummond GB (2009). Reporting ethical matters in The Journal of Physiology: standards and advice. J Physiol 587, 713-719.
20. Edwards DA, Kim J & Alger BE (2006). Multiple mechanisms of endocannabinoid response initiation in hippocampus. J Neurophysiol 95, 67-75.
21. Edwards DA, Zhang L & Alger BE (2008). Metaplastic control of the endocannabinoid system at inhibitory synapses in hippocampus. Proc Natl Acad Sci U S A 105, 8142-8147.
22. 1 receptor in the primate neocortex: a regional and laminar analysis. Cereb Cortex 17, 175-191.
23. Eggan SM, Melchitzky DS, Sesack SR, Fish KN & Lewis DA (2010). Relationship of cannabinoid CB1 receptor and cholecystokinin immunoreactivity in monkey dorsolateral prefrontal cortex. Neuroscience 169, 1651-1661.
24. Fanselow EE, Richardson KA & Connors BW (2008). Selective, state-dependent activation of somatostatin-expressing inhibitory interneurons in mouse neocortex. J Neurophysiol 100, 2640-2652.
25. Fegley D, Gaetani S, Duranti A, Tontini A, Mor M, Tarzia G & Piomelli D (2005). Characterization of the fatty acid amide hydrolase inhibitor cyclohexyl carbamic acid 3'-carbamoyl-biphenyl-3-yl ester (URB597): effects on anandamide and oleoylethanolamide deactivation. J Pharmacol Exp Ther 313, 352-358.
26. Fortin DA & Levine ES (2007). Differential effects of endocannabinoids on glutamatergic and GABAergic inputs to layer 5 pyramidal neurons. Cereb Cortex 17, 163-174.
27. Fortin DA, Trettel J & Levine ES (2004). Brief trains of action potentials enhance pyramidal neuron excitability via endocannabinoid-mediated suppression of inhibition. J Neurophysiol 92, 2105-2112.
28. Freund TF & Katona I (2007). Perisomatic inhibition. Neuron 56, 33-42.
29. Galarreta M, Erdelyi F, Szabo G & Hestrin S (2008). Cannabinoid sensitivity and synaptic properties of 2 GABAergic networks in the neocortex. Cereb Cortex 18, 2296-2305.
30. Gao Y, Vasilyev DV, Goncalves MB, Howell FV, Hobbs C, Reisenberg M, Shen R, Zhang MY, Strassle BW, Lu P, Mark L, Piesla MJ, Deng K, Kouranova EV, Ring RH, Whiteside GT, Bates B, Walsh FS, Williams G, Pangalos MN, Samad TA & Doherty P (2010). Loss of retrograde endocannabinoid signaling and reduced adult neurogenesis in diacylglycerol lipase knock-out mice. J Neurosci 30, 2017-2024.
31. Glickfeld LL & Scanziani M (2006). Distinct timing in the activity of cannabinoid-sensitive and cannabinoid-insensitive basket cells. Nat Neurosci 9, 807-815.
32. Goldman-Rakic PS (1995). Cellular basis of working memory. Neuron 14, 477-485.
33. Gonzalez-Burgos G, Rotaru DC, Zaitsev AV, Povysheva NV & Lewis DA (2009). GABA transporter GAT1 prevents spillover at proximal and distal GABA synapses onto primate prefrontal cortex neurons. J Neurophysiol 101, 533-547.
34. Gulyas AI, Cravatt BF, Bracey MH, Dinh TP, Piomelli D, Boscia F & Freund TF (2004). Segregation of two endocannabinoid-hydrolyzing enzymes into pre- and postsynaptic compartments in the rat hippocampus, cerebellum and amygdala. Eur J Neurosci 20, 441-458.
35. Gulyas AI, Szabo GG, Ulbert I, Holderith N, Monyer H, Erdelyi F, Szabo G, Freund TF & Hajos N (2010). Parvalbumin-containing fast-spiking basket cells generate the field potential oscillations induced by cholinergic receptor activation in the hippocampus. J Neurosci 30, 15134-15145.
36. Hájos N & Mody I (2009). Establishing a physiological environment for visualized in vitro brain slice recordings by increasing oxygen supply and modifying aCSF content. J Neurosci Methods 183, 107-113.
37. Hansson AC, Bermudez-Silva FJ, Malinen H, Hyytia P, Sanchez-Vera I, Rimondini R, Rodriguez de FF, Kunos G, Sommer WH & Heilig M (2007). Genetic impairment of frontocortical endocannabinoid degradation and high alcohol preference. Neuropsychopharmacology 32, 117-126.
38. Harkany T, Holmgren C, Hartig W, Qureshi T, Chaudhry FA, Storm-Mathisen J, Dobszay MB, Berghuis P, Schulte G, Sousa KM, Fremeau RT Jr, Edwards RH, Mackie K, Ernfors P & Zilberter Y (2004). Endocannabinoid-independent retrograde signaling at inhibitory synapses in layer 2/3 of neocortex: involvement of vesicular glutamate transporter 3. J Neurosci 24, 4978-4988.
39. Hashimotodani Y, Ohno-Shosaku T & Kano M (2007). Presynaptic monoacylglycerol lipase activity determines basal endocannabinoid tone and terminates retrograde endocannabinoid signaling in the hippocampus. J Neurosci 27, 1211-1219.
40. Hashimotodani Y, Ohno-Shosaku T, Maejima T, Fukami K & Kano M (2008). Pharmacological evidence for the involvement of diacylglycerol lipase in depolarization-induced endocanabinoid release. Neuropharmacology 54, 58-67.
41. Heifets BD & Castillo PE (2009). Endocannabinoid signaling and long-term synaptic plasticity. Annu Rev Physiol 71, 283-306.
42. Hill EL, Gallopin T, Ferezou I, Cauli B, Rossier J, Schweitzer P & Lambolez B (2007). Functional CB1 receptors are broadly expressed in neocortical GABAergic and glutamatergic neurons. J Neurophysiol 97, 2580-2589.
43. 1 receptor-deficient mice parallel the effects of chronic stress. Cereb Cortex 21, 2056-2064.
44. Hoover HS, Blankman JL, Niessen S & Cravatt BF (2008). Selectivity of inhibitors of endocannabinoid biosynthesis evaluated by activity-based protein profiling. Bioorg Med Chem Lett 18, 5838-5841.
45. Hyman JM, Zilli EA, Paley AM & Hasselmo ME (2010). Working memory performance correlates with prefrontal-hippocampal theta interactions but not with prefrontal neuron firing rates. Front Integr Neurosci 4, 2.
46. Joyner AL (2000). Gene Targeting: A Practical Approach Oxford University Press, Oxford, UK.
47. Jung KM, Astarita G, Thongkham D & Piomelli D (2011). Diacylglycerol lipase-α and -β control neurite outgrowth in Neuro-2a cells through distinct molecular mechanisms. Mol Pharmacol 80, 60-67.
48. Kano M, Ohno-Shosaku T, Hashimotodani Y, Uchigashima M & Watanabe M (2009). Endocannabinoid-mediated control of synaptic transmission. Physiol Rev 89, 309-380.
49. Katona I & Freund TF (2008). Endocannabinoid signaling as a synaptic circuit breaker in neurological disease. Nat Med 14, 923-930.
50. Katona I, Sperlagh B, Sik A, Kafalvi A, Vizi ES, Mackie K & Freund TF (1999). Presynaptically located CB1 cannabinoid receptors regulate GABA release from axon terminals of specific hippocampal interneurons. J Neurosci 19, 4544-4558.
51. Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K & Freund TF (2006). Molecular composition of the endocannabinoid system at glutamatergic synapses. J Neurosci 26, 5628-5637.
52. Kawaguchi Y (1997). Selective cholinergic modulation of cortical GABAergic cell subtypes. J Neurophysiol 78, 1743-1747.
53. Kim J & Alger BE (2010). Reduction in endocannabinoid tone is a homeostatic mechanism for specific inhibitory synapses. Nat Neurosci 13, 592-600.
54. Kim J, Isokawa M, Ledent C & Alger BE (2002). Activation of muscarinic acetylcholine receptors enhances the release of endogenous cannabinoids in the hippocampus. J Neurosci 22, 10182-10191.
55. Lafourcade M, Elezgarai I, Mato S, Bakiri Y, Grandes P & Manzoni OJ (2007). Molecular components and functions of the endocannabinoid system in mouse prefrontal cortex. PLoS One 2, e709.
56. Lafourcade M, Larrieu T, Mato S, Duffaud A, Sepers M, Matias I, De Smedt-Peyrusse V, Labrousse VF, Bretillon L, Matute C, Rodriguez-Puertas R, Laye S & Manzoni OJ (2011). Nutritional omega-3 deficiency abolishes endocannabinoid-mediated neuronal functions. Nat Neurosci 14, 345-350.
57. Lapish CC, Durstewitz D, Chandler LJ & Seamans JK (2008). Successful choice behavior is associated with distinct and coherent network states in anterior cingulate cortex. Proc Natl Acad Sci U S A 105, 11963-11968.
58. Lee SH, Foldy C & Soltesz I (2010). Distinct endocannabinoid control of GABA release at perisomatic and dendritic synapses in the hippocampus. J Neurosci 30, 7993-8000.
59. Lenz RA, Wagner JJ & Alger BE (1998). N- and L-type calcium channel involvement in depolarization-induced suppression of inhibition in rat hippocampal CA1 cells. J Physiol 512, 61-73.
60. 1 receptors in the medial prefrontal cortex modulate the expression of contextual fear conditioning. Int J Neuropsychopharmacol 13, 1163-1173.
61. Losonczy A, Biro AA & Nusser Z (2004). Persistently active cannabinoid receptors mute a subpopulation of hippocampal interneurons. Proc Natl Acad Sci U S A 101, 1362-1367.
62. Lourenço J, Matias I, Marsicano G & Mulle C (2011). Pharmacological activation of kainate receptors drives endocannabinoid mobilization. J Neurosci 31, 3143-3147.
63. Ludanyi A, Hu SS, Yamazaki M, Tanimura A, Piomelli D, Watanabe M, Kano M, Sakimura K, Magloczky Z, Mackie K, Freund TF & Katona I (2011). Complementary synaptic distribution of enzymes responsible for synthesis and inactivation of the endocannabinoid 2-arachidonoylglycerol in the human hippocampus. Neuroscience 174, 50-63.
64. Makara JK, Katona I, Nyíri G, Németh B, Ledent C, Watanabe M, de VJ, Freund TF & Hájos N (2007). Involvement of nitric oxide in depolarization-induced suppression of inhibition in hippocampal pyramidal cells during activation of cholinergic receptors. J Neurosci 27, 10211-10222.
65. Marinelli S, Pacioni S, Cannich A, Marsicano G & Bacci A (2009). Self-modulation of neocortical pyramidal neurons by endocannabinoids. Nat Neurosci 12, 1488-1490.
66. Martin LA & Alger BE (1999). Muscarinic facilitation of the occurrence of depolarization-induced suppression of inhibition in rat hippocampus. Neuroscience 92, 61-71.
67. A receptor-mediated IPSCs to depolarization-induced suppression of inhibition in rat hippocampus. J Physiol 532, 685-700.
68. Matuszak N, Muccioli GG, Labar G & Lambert DM (2009). Synthesis and in vitro evaluation of N-substituted maleimide derivatives as selective monoglyceride lipase inhibitors. J Med Chem 52, 7410-7420.
69. Min R, Di Marzo V & Mansvelder HD (2010a). DAG lipase involvement in depolarization-induced suppression of inhibition: does endocannabinoid biosynthesis always meet the demand? Neuroscientist 16, 608-613.
70. Min R, Testa-Silva G, Heistek TS, Canto CB, Lodder JC, Bisogno T, Di Marzo V, Brussaard AB, Burnashev N & Mansvelder HD (2010b). Diacylglycerol lipase is not involved in depolarization-induced suppression of inhibition at unitary inhibitory connections in mouse hippocampus. J Neurosci 30, 2710-2715.
71. Monory K, Massa F, Egertova M, Eder M, Blaudzun H, Westenbroek R, Kelsch W, Jacob W, Marsch R, Ekker M, Long J, Rubenstein JL, Goebbels S, Nave KA, During M, Klugmann M, Wolfel B, Dodt HU, Zieglgansberger W, Wotjak CT, Mackie K, Elphick MR, Marsicano G & Lutz B (2006). The endocannabinoid system controls key epileptogenic circuits in the hippocampus. Neuron 51, 455-466.
72. Neu A, Foldy C & Soltesz I (2007). Postsynaptic origin of CB1-dependent tonic inhibition of GABA release at cholecystokinin-positive basket cell to pyramidal cell synapses in the CA1 region of the rat hippocampus. J Physiol 578, 233-247.
73. 1 cannabinoid receptors are enriched in the perisynaptic annulus and on preterminal segments of hippocampal GABAergic axons. Neuroscience 136, 811-822.
74. Ortar G, Bisogno T, Ligresti A, Morera E, Nalli M & Di Marzo V (2008). Tetrahydrolipstatin analogues as modulators of endocannabinoid 2-arachidonoylglycerol metabolism. J Med Chem 51, 6970-6979.
75. Pan B, Wang W, Long JZ, Sun D, Hillard CJ, Cravatt BF & Liu QS (2009). Blockade of 2-arachidonoylglycerol hydrolysis by selective monoacylglycerol lipase inhibitor 4-nitrophenyl 4-(dibenzo[d][1, 3]dioxol-5-yl(hydroxy)methyl)piperidine-1-carboxylate (JZL184) enhances retrograde endocannabinoid signaling. J Pharmacol Exp Ther 331, 591-597.
76. Pitler TA & Alger BE (1992a). Cholinergic excitation of GABAergic interneurons in the rat hippocampal slice. J Physiol 450, 127-142.
77. A responses in hippocampal pyramidal cells. J Neurosci 12, 4122-4132.
78. Preuss TM (1995). Do rats have prefrontal cortex? The Rose-Woolsey-Akert program reconsidered. J Cogn Neurosci 7, 1-24.
79. Rubino T, Realini N, Castiglioni C, Guidali C, Vigano D, Marras E, Petrosino S, Perletti G, Maccarrone M, Di Marzo V & Parolaro D (2008). Role in anxiety behavior of the endocannabinoid system in the prefrontal cortex. Cereb Cortex 18, 1292-1301.
80. Saario SM, Salo OM, Nevalainen T, Poso A, Laitinen JT, Jarvinen T & Niemi R (2005). Characterization of the sulfhydryl-sensitive site in the enzyme responsible for hydrolysis of 2-arachidonoyl-glycerol in rat cerebellar membranes. Chem Biol 12, 649-656.
81. Safo PK & Regehr WG (2005). Endocannabinoids control the induction of cerebellar LTD. Neuron 48, 647-659.
82. Schlosburg JE, Blankman JL, Long JZ, Nomura DK, Pan B, Kinsey SG, Nguyen PT, Ramesh D, Booker L, Burston JJ, Thomas EA, Selley DE, Sim-Selley LJ, Liu QS, Lichtman AH & Cravatt BF (2010). Chronic monoacylglycerol lipase blockade causes functional antagonism of the endocannabinoid system. Nat Neurosci 13, 1113-1119.
83. Schrick JJ, Vogel P, Abuin A, Hampton B & Rice DS (2006). ADP-ribosylation factor-like 3 is involved in kidney and photoreceptor development. Am J Pathol 168, 1288-1298.
84. Seamans JK, Lapish CC & Durstewitz D (2008). Comparing the prefrontal cortex of rats and primates: insights from electrophysiology. Neurotox Res 14, 249-262.
85. Silver J & Keerikatte V (1989). Novel use of polymerase chain reaction to amplify cellular DNA adjacent to an integrated provirus. J Virol 63, 1924-1928.
86. Sjostrom PJ, Turrigiano GG & Nelson SB (2003). Neocortical LTD via coincident activation of presynaptic NMDA and cannabinoid receptors. Neuron 39, 641-654.
87. Straiker A, Hu SS, Long JZ, Arnold A, Wager-Miller J, Cravatt BF & Mackie K (2009). Monoacylglycerol lipase limits the duration of endocannabinoid-mediated depolarization-induced suppression of excitation in autaptic hippocampal neurons. Mol Pharmacol 76, 1220-1227.
88. Szabo B, Urbanski MJ, Bisogno T, Di Marzo V, Mendiguren A, Baer WU & Freiman I (2006). Depolarization-induced retrograde synaptic inhibition in the mouse cerebellar cortex is mediated by 2-arachidonoylglycerol. J Physiol 577, 263-280.
89. Szabó GG, Holderith N, Gulyás AI, Freund TF & Hájos N (2010). Distinct synaptic properties of perisomatic inhibitory cell types and their different modulation by cholinergic receptor activation in the CA3 region of the mouse hippocampus. Eur J Neurosci 31, 2234-2246.
90. Tanimura A, Yamazaki M, Hashimotodani Y, Uchigashima M, Kawata S, Abe M, Kita Y, Hashimoto K, Shimizu T, Watanabe M, Sakimura K & Kano M (2010). The endocannabinoid 2-arachidonoylglycerol produced by diacylglycerol lipase α mediates retrograde suppression of synaptic transmission. Neuron 65, 320-327.
91. Trettel J, Fortin DA & Levine ES (2004). Endocannabinoid signalling selectively targets perisomatic inhibitory inputs to pyramidal neurones in juvenile mouse neocortex. J Physiol 556, 95-107.
92. van Aerde KI, Heistek TS & Mansvelder HD (2008). Prelimbic and infralimbic prefrontal cortex interact during fast network oscillations. PLoS One 3, e2725.
93. van Aerde KI, Mann EO, Canto CB, Heistek TS, Linkenkaer-Hansen K, Mulder AB, van der Roest M, Paulsen O, Brussaard AB & Mansvelder HD (2009). Flexible spike timing of layer 5 neurons during dynamic beta oscillation shifts in rat prefrontal cortex. J Physiol 587, 5177-5196.
94. Varga C, Lee SY & Soltesz I (2010). Target-selective GABAergic control of entorhinal cortex output. Nat Neurosci 13, 822-824.
95. Volk DW, Eggan SM & Lewis DA (2010). Alterations in metabotropic glutamate receptor 1α and regulator of G protein signaling 4 in the prefrontal cortex in schizophrenia. Am J Psychiatry 167, 1489-1498.
96. Wilson RI, Kunos G & Nicoll RA (2001). Presynaptic specificity of endocannabinoid signaling in the hippocampus. Neuron 31, 453-462.
97. Wilson RI & Nicoll RA (2001). Endogenous cannabinoids mediate retrograde signalling at hippocampal synapses. Nature 410, 588-592.
98. Yoshida T, Fukaya M, Uchigashima M, Miura E, Kamiya H, Kano M & Watanabe M (2006). Localization of diacylglycerol lipase-α around postsynaptic spine suggests close proximity between production site of an endocannabinoid, 2-arachidonoyl-glycerol, and presynaptic cannabinoid CB1 receptor. J Neurosci 26, 4740-4751.
99. Zaitsev AV, Povysheva NV, Lewis DA & Krimer LS (2007). P/Q-type, but not N-type, calcium channels mediate GABA release from fast-spiking interneurons to pyramidal cells in rat prefrontal cortex. J Neurophysiol 97, 3567-3573.
100. Zambrowicz BP, Abuin A, Ramirez-Solis R, Richter LJ, Piggott J, BeltrandelRio H, Buxton EC, Edwards J, Finch RA, Friddle CJ, Gupta A, Hansen G, Hu Y, Huang W, Jaing C, Key BW Jr, Kipp P, Kohlhauff B, Ma ZQ, Markesich D, Payne R, Potter DG, Qian N, Shaw J, Schrick J, Shi ZZ, Sparks MJ, Van SI, Vogel P, Walke W, Xu N, Zhu Q, Person C & Sands AT (2003). Wnk1 kinase deficiency lowers blood pressure in mice: a gene-trap screen to identify potential targets for therapeutic intervention. Proc Natl Acad Sci U S A 100, 14109-14114.
101. Zambrowicz BP, Friedrich GA, Buxton EC, Lilleberg SL, Person C & Sands AT (1998). Disruption and sequence identification of 2, 000 genes in mouse embryonic stem cells. Nature 392, 608-611.
102. 2+ or by metabotropic glutamate receptors appear to arise from different pools of diacylglycerol lipase 2. PLoS One 6, e16305.
103. Zilberter Y (2000). Dendritic release of glutamate suppresses synaptic inhibition of pyramidal neurons in rat neocortex. J Physiol 528, 489-496.